Effects of clinical decision support on venous thromboembolism risk assessment, prophylaxis, and prevention at a university teaching hospital

Galanter, William L.; Thambi, Mathew; Rosencranz, Holly; Shah, Bobby; Falck, Suzanne; Fang-Ju Lin; Nutescu, Edith; Lambert, Bruce
August 2010
American Journal of Health-System Pharmacy;8/1/2010, Vol. 67 Issue 15, p1265
Academic Journal
Purpose. The implementation of a mandatory assessment of risk for venous thromboembolism (VTE) in a health system's electronic medical record (EMR) and clinical decision-support (CDS) system was evaluated to measure its effect on the use of pharmacologic prophylaxis and the occurrence of VTE and bleeding events. Methods. A commercially available CDS system was used in designing the automated CDS intervention. During computerized order entry, the system delivered alerts prompting clinician risk assessment and also delivered alerts under circumstances suggesting less-than-optimal prophylaxis. Rates of pharmacologic prophylaxis, clinically diagnosed hospital-acquired VTE, and hospital-acquired bleeding events were measured during one year before and one year after implementation. Results. After adjustment for patient age, sex, and high-risk comorbidities, the data showed a postimplementation increase in the percentage of patients who received pharmacologic prophylaxis at some time during their admission from 25.9% to 36.8% (p < 0.001). The rate of VTE for the entire hospital did not change significantly, but a significant reduction among patients on medical units was observed, from 0.55% to 0.33% (p = 0.02). There was no increase in either major or minor bleeding events. Conclusion. Without increasing the risk of bleeding, a CDS system requiring clinicians to document VTE risk assessment in the EMR promoted improved rates of pharmacologic prophylaxis at any time during an admission and a decreased risk of VTE in general medical patients but not all adult patients.


Related Articles

  • Dental Surgery for Patients on Anticoagulants. Khaled, K. B. // Ontario Dentist;Dec2006, Vol. 83 Issue 10, p20 

    The article discusses issues involving patients on anticoagulant therapy needing dental surgery. Patients on oral anticoagulants do not have equal risk of thromboembolism. This is something that depends on the patient's underlying medical condition. The author explains the importance of the...

  • SIGN guideline on venous thromboembolism. Linden, Belinda // British Journal of Cardiac Nursing;Jul2011, Vol. 6 Issue 7, p342 

    The article offers information on the guidelines of Scottish Intercollegiate Guidelines Network (SIGN) for the management and prevention of venous thromboembolism. It says that the new guideline launched in December 2010 will contain evidences including diagnostic methods, anti-thrombotic...

  • ReplyRe: Anticoagulation in acute stroke patients with AF and prosthetic valves. Mudd, Paul D.; James, Martin A. // Age & Ageing;Sep2011, Vol. 40 Issue 5, p647 

    A response from Paul D. Mudd and Martin A. James to a letter to the editor about their article "Anticoagulation for atrial fibrillation: should warfarin be temporarily stopped or continued after acute cardioembolic stroke?" in the 2010 issue is presented.

  • ASHP Therapeutic Position Statement on the Role of Pharmacotherapy in Preventing Venous Thromboembolism in Hospitalized Patients. Mahan, Charles E.; Spyropoulos, Alex C. // American Journal of Health-System Pharmacy;12/15/2012, Vol. 69 Issue 24, p2174 

    The article discusses the therapeutic position statement by the American Society of Health System Pharmacists (ASHP) with regard to the role of pharmacotherapy in the prevention of venous thromboembolism (VTE) in hospitalized patients. The various risk factors for VTE and different treatment...

  • The up-to-date management of venous thromboembolism. Chakrabarti, Anob M. // Clinical Medicine;Aug2015, Vol. 15 Issue 4, p367 

    There have been a number of developments in the management of venous thromboembolism over the past few years. Old questions, such as thrombolysis, have been revisited in recent trials. New initiatives, such as ambulatory care pathways, are being established across the country. This conference...

  • Tapentadol for pain; enoxaparin after prosthetic valve replacement. DeDea, Larissa // JAAPA: Journal of the American Academy of Physician Assistants (;Jul2011, Vol. 24 Issue 7, p14 

    The article presents questions and answers related to drugs such as the meaning of tapentadol or nucynta and the guidelines for bridging anticoagulation using enoxaparin following a prosthetic valve replacement surgery.

  • Venous thromboembolism and anticoagulants in pregnancy.  // British Medical Journal;11/22/1975, Vol. 4 Issue 5994, p421 

    Describes the aspects of venous thromboembolism and anticoagulants in pregnancy. Risk of puerperal venous thromboembolism; Suppression of lactation by estrogens; Frequency of fatal pulmonary embolism.

  • Monitoring quality: not just box-ticking. Tagney, Jenny // British Journal of Cardiac Nursing;Feb2013, Vol. 8 Issue 2, p57 

    The author offers clinical article pertaining to new agents for anticoagulation and treatment of pulmonary embolus with thrombolysis, the risk assessment processes for venous thromboembolism (VTE), recommended by National Institute for Healthcare and Clinical Excellence [NICE] and Scottish...

  • The Risk of Recurrent Venous Thromboembolism in Men and Women. Kyrle, Paul A.; Minar, Erich; Bialonczyk, Christine; Hirschl, Mirko; Weltermann, Ansgar; Eichinger, Sabine // New England Journal of Medicine;6/17/2004, Vol. 350 Issue 25, p2558 

    Background: Whether a patient's sex is associated with the risk of recurrent venous thromboembolism is unknown. Methods: We studied 826 patients for an average of 36 months after a first episode of spontaneous venous thromboembolism and the withdrawal of oral anticoagulants. We excluded pregnant...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics